| NCT03750201 |
A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty |
https://ClinicalTrials.gov/show/NCT03750201 |
Recruiting |
Belkin Laser Ltd. |
2022-04-30 |
| NCT03395535 |
Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03395535 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2017-12-25 |
| NCT03657797 |
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03657797 |
Completed |
Nicox Ophthalmics, Inc. |
2019-08-23 |
| NCT03825380 |
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients |
https://ClinicalTrials.gov/show/NCT03825380 |
Recruiting |
Laboratoires Thea |
2020-04-30 |
| NCT03822559 |
A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03822559 |
Recruiting |
Santen Pharmaceutical Co., Ltd. |
2022-03-31 |
| NCT03310580 |
Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03310580 |
Completed |
Aerie Pharmaceuticals |
2018-10-25 |
| NCT03293992 |
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03293992 |
Completed |
Hoffmann-La Roche |
2017-12-15 |
| NCT03284853 |
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03284853 |
Active, not recruiting |
Aerie Pharmaceuticals |
2020-12-31 |
| NCT03257813 |
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) |
https://ClinicalTrials.gov/show/NCT03257813 |
Completed |
Laboratorios Sophia S.A de C.V. |
2017-03-01 |
| NCT03233308 |
Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) |
https://ClinicalTrials.gov/show/NCT03233308 |
Completed |
Aerie Pharmaceuticals |
2018-04-19 |
| NCT03216902 |
A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study |
https://ClinicalTrials.gov/show/NCT03216902 |
Completed |
Santen Inc. |
2018-02-27 |
| NCT03204487 |
A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness |
https://ClinicalTrials.gov/show/NCT03204487 |
Completed |
Ordination Dr. Hommer |
2017-04-25 |
| NCT03201354 |
Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery |
https://ClinicalTrials.gov/show/NCT03201354 |
Completed |
Institut Catala de Retina |
2015-06-30 |
| NCT03192826 |
Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy |
https://ClinicalTrials.gov/show/NCT03192826 |
Completed |
University Hospital of Patras |
2017-07-08 |
| NCT03187418 |
Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma |
https://ClinicalTrials.gov/show/NCT03187418 |
Active, not recruiting |
Centre hospitalier de l’Université de Montréal (CHUM) |
2019-02-28 |
| NCT03131167 |
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT03131167 |
Completed |
Shire |
2018-05-30 |
| NCT02993445 |
Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02993445 |
Completed |
Temple University |
2016-02-29 |
| NCT02989909 |
Clinical Evaluation of CATS Tonometer Prism |
https://ClinicalTrials.gov/show/NCT02989909 |
Completed |
Intuor Technologies, Inc. |
2017-11-30 |
| NCT02981446 |
A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT |
https://ClinicalTrials.gov/show/NCT02981446 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2019-01-31 |
| NCT02967614 |
KJ-TFC-004 Drug-drug Interaction Study |
https://ClinicalTrials.gov/show/NCT02967614 |
Completed |
Kukje Pharma |
2017-12-31 |
| NCT02874846 |
Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT02874846 |
Completed |
Aerie Pharmaceuticals |
2016-09-30 |
| NCT02858284 |
Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02858284 |
Completed |
EyeSonix |
2018-08-22 |
| NCT02829996 |
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG |
https://ClinicalTrials.gov/show/NCT02829996 |
Completed |
Inotek Pharmaceuticals Corporation |
2017-05-24 |
| NCT02822742 |
A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study |
https://ClinicalTrials.gov/show/NCT02822742 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2017-04-28 |
| NCT02822729 |
A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study |
https://ClinicalTrials.gov/show/NCT02822729 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2017-11-09 |
| NCT04442464 |
Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear |
https://ClinicalTrials.gov/show/NCT04442464 |
Recruiting |
Mayo Clinic |
2021-12-31 |
| NCT02754570 |
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure |
https://ClinicalTrials.gov/show/NCT02754570 |
Completed |
University of Colorado, Denver |
2017-12-31 |
| NCT02743780 |
A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma |
https://ClinicalTrials.gov/show/NCT02743780 |
Completed |
Alcon Research |
2016-09-20 |
| NCT02742649 |
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02742649 |
Completed |
ForSight Vision5, Inc. |
2016-12-31 |
| NCT02710916 |
SD-OCT Multimodal Analysis in GLaucoma |
https://ClinicalTrials.gov/show/NCT02710916 |
Completed |
University Hospital, Bordeaux |
2018-12-21 |
| NCT02674854 |
Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02674854 |
Completed |
Aerie Pharmaceuticals |
2017-03-31 |
| NCT02623738 |
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- |
https://ClinicalTrials.gov/show/NCT02623738 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2017-02-10 |
| NCT02622334 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). |
https://ClinicalTrials.gov/show/NCT02622334 |
Completed |
Hoffmann-La Roche |
2016-07-28 |
| NCT02617459 |
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02617459 |
Recruiting |
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
2020-12-31 |
| NCT02585375 |
Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT |
https://ClinicalTrials.gov/show/NCT02585375 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT02636946 |
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02636946 |
Active, not recruiting |
Allergan |
2021-02-28 |
| NCT02507687 |
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02507687 |
Recruiting |
Allergan |
2021-10-31 |
| NCT02571712 |
Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02571712 |
Completed |
Allergan |
2018-06-21 |
| NCT02565173 |
Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT02565173 |
Completed |
Inotek Pharmaceuticals Corporation |
2016-11-30 |
| NCT02558400 |
Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02558400 |
Completed |
Aerie Pharmaceuticals |
2017-05-17 |
| NCT02558374 |
Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02558374 |
Completed |
Aerie Pharmaceuticals |
2016-12-31 |
| NCT02539758 |
The Effect of Ocular Massage on the Management of Elevated Intraocular Pressure After Acute Angle Closure |
https://ClinicalTrials.gov/show/NCT02539758 |
Completed |
Tianjin Medical University Eye Hospital |
2014-09-30 |
| NCT02537015 |
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert |
https://ClinicalTrials.gov/show/NCT02537015 |
Completed |
ForSight Vision5, Inc. |
2016-08-11 |
| NCT02531152 |
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02531152 |
Completed |
Sanofi |
2016-04-30 |
| NCT02512042 |
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes |
https://ClinicalTrials.gov/show/NCT02512042 |
Completed |
Actavis Inc. |
2016-04-30 |
| NCT02466399 |
POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT02466399 |
Completed |
Peregrine Ophthalmic |
2016-04-30 |
| NCT02434250 |
Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy |
https://ClinicalTrials.gov/show/NCT02434250 |
Completed |
University of Zurich |
2016-10-31 |
| NCT02419508 |
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) |
https://ClinicalTrials.gov/show/NCT02419508 |
Completed |
Alcon Research |
2018-02-27 |
| NCT02390245 |
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study |
https://ClinicalTrials.gov/show/NCT02390245 |
Active, not recruiting |
Wills Eye |
2019-09-30 |
| NCT02358369 |
Dose-Ranging Study of the Bimatoprost Ocular Insert |
https://ClinicalTrials.gov/show/NCT02358369 |
Completed |
ForSight Vision5, Inc. |
2015-08-31 |
| NCT02339584 |
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) |
https://ClinicalTrials.gov/show/NCT02339584 |
Completed |
Alcon Research |
2016-11-01 |
| NCT02338362 |
Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma |
https://ClinicalTrials.gov/show/NCT02338362 |
Completed |
University Health Network, Toronto |
2015-02-28 |
| NCT02312544 |
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02312544 |
Completed |
Ocular Therapeutix, Inc. |
2015-09-30 |
| NCT02278614 |
Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients |
https://ClinicalTrials.gov/show/NCT02278614 |
Completed |
Laboratoires Thea |
2015-11-30 |
| NCT02250651 |
Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02250651 |
Completed |
Allergan |
2018-10-25 |
| NCT02250612 |
SYL040012, Treatment for Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT02250612 |
Completed |
Sylentis, S.A. |
2015-08-31 |
| NCT02247804 |
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02247804 |
Completed |
Allergan |
2018-02-19 |
| NCT02246764 |
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02246764 |
Completed |
Aerie Pharmaceuticals |
2016-12-31 |
| NCT02207621 |
Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02207621 |
Completed |
Aerie Pharmaceuticals |
2016-03-31 |
| NCT02207491 |
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02207491 |
Completed |
Aerie Pharmaceuticals |
2015-03-31 |
| NCT02179008 |
Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02179008 |
Completed |
Santen Inc. |
2015-01-31 |
| NCT02167035 |
Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) |
https://ClinicalTrials.gov/show/NCT02167035 |
Completed |
Cornerstone Health Care, PA |
2018-03-31 |
| NCT02157025 |
A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics |
https://ClinicalTrials.gov/show/NCT02157025 |
Recruiting |
Nova Southeastern University |
2020-12-31 |
| NCT02143843 |
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product |
https://ClinicalTrials.gov/show/NCT02143843 |
Completed |
ForSight Vision5, Inc. |
2015-12-31 |
| NCT02140060 |
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02140060 |
Completed |
Alcon Research |
2014-11-30 |
| NCT02129673 |
A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02129673 |
Completed |
ViSci Ltd. |
2017-05-31 |
| NCT02108288 |
Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers |
https://ClinicalTrials.gov/show/NCT02108288 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2014-05-31 |
| NCT02105285 |
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02105285 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2015-01-31 |
| NCT02105272 |
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02105272 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2015-03-31 |
| NCT02102750 |
A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02102750 |
Completed |
Santen Oy |
2017-05-29 |
| NCT02097719 |
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02097719 |
Completed |
Allergan |
2014-12-31 |
| NCT02083289 |
A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) |
https://ClinicalTrials.gov/show/NCT02083289 |
Completed |
Ono Pharmaceutical Co. Ltd |
2014-12-31 |
| NCT02061683 |
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02061683 |
Completed |
Allergan |
2011-06-24 |
| NCT02059278 |
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02059278 |
Completed |
Nephron Pharmaceuticals Corporation |
2015-01-31 |
| NCT01318252 |
AL-54478 Proof of Concept Study |
https://ClinicalTrials.gov/show/NCT01318252 |
Completed |
Alcon Research |
2011-10-31 |
| NCT01310777 |
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01310777 |
Completed |
Alcon Research |
2013-01-31 |
| NCT01309204 |
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01309204 |
Completed |
Alcon Research |
2013-01-31 |
| NCT01306461 |
Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations |
https://ClinicalTrials.gov/show/NCT01306461 |
Completed |
Santen Oy |
2012-04-30 |
| NCT01302249 |
AR-12286 in Combination With Latanoprost |
https://ClinicalTrials.gov/show/NCT01302249 |
Completed |
Aerie Pharmaceuticals |
2011-12-31 |
| NCT01298700 |
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01298700 |
Completed |
Allergan |
2016-12-06 |
| NCT01298687 |
Divided Dose of TRAVATAN® |
https://ClinicalTrials.gov/show/NCT01298687 |
Completed |
Alcon Research |
2011-04-30 |
| NCT01297920 |
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% |
https://ClinicalTrials.gov/show/NCT01297920 |
Completed |
Alcon Research |
2012-06-30 |
| NCT01297517 |
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% |
https://ClinicalTrials.gov/show/NCT01297517 |
Completed |
Alcon Research |
2012-03-31 |
| NCT01292460 |
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies |
https://ClinicalTrials.gov/show/NCT01292460 |
Completed |
Santen Oy |
2012-09-30 |
| NCT01291108 |
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01291108 |
Completed |
Allergan |
2011-10-31 |
| NCT01279083 |
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01279083 |
Completed |
Santen Inc. |
2011-11-30 |
| NCT01271686 |
24-hour IOP-lowering Effect of 0.01% Bimatoprost |
https://ClinicalTrials.gov/show/NCT01271686 |
Completed |
University of California, San Diego |
2012-10-31 |
| NCT02057575 |
Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT02057575 |
Completed |
Aerie Pharmaceuticals |
2014-06-30 |
| NCT02020512 |
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02020512 |
Completed |
Allergan |
2012-12-31 |
| NCT02017327 |
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose |
https://ClinicalTrials.gov/show/NCT02017327 |
Completed |
Laboratoires Thea |
2016-07-31 |
| NCT02014142 |
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT02014142 |
Completed |
Mati Therapeutics Inc. |
2016-12-31 |
| NCT02003391 |
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT02003391 |
Completed |
Alcon Research |
2015-05-31 |
| NCT01995136 |
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma |
https://ClinicalTrials.gov/show/NCT01995136 |
Completed |
Alcon Research |
2014-06-30 |
| NCT01987323 |
Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01987323 |
Completed |
Singapore Eye Research Institute |
2013-06-30 |
| NCT01979913 |
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More |
https://ClinicalTrials.gov/show/NCT01979913 |
Completed |
Ordination Dr. Hommer |
2014-04-30 |
| NCT01978600 |
Evaluation of Intraocular Pressure Using Simbrinzaâ„¢ in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01978600 |
Completed |
Alcon Research |
2014-03-31 |
| NCT01975714 |
Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study |
https://ClinicalTrials.gov/show/NCT01975714 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2015-02-28 |
| NCT01937312 |
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue |
https://ClinicalTrials.gov/show/NCT01937312 |
Completed |
Alcon Research |
2014-05-31 |
| NCT01937299 |
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® |
https://ClinicalTrials.gov/show/NCT01937299 |
Completed |
Alcon Research |
2014-04-30 |
| NCT01936389 |
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma |
https://ClinicalTrials.gov/show/NCT01936389 |
Completed |
Robert Ritch, MD, LLC. |
2014-10-31 |
| NCT01917383 |
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01917383 |
Completed |
Inotek Pharmaceuticals Corporation |
2014-08-31 |
| NCT01915940 |
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01915940 |
Completed |
ForSight Vision5, Inc. |
2014-09-30 |
| NCT01895972 |
Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT |
https://ClinicalTrials.gov/show/NCT01895972 |
Completed |
Bausch & Lomb Incorporated |
2015-04-02 |
| NCT01881126 |
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01881126 |
Completed |
Allergan |
2014-10-31 |
| NCT01868126 |
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01868126 |
Completed |
Santen Inc. |
2013-08-31 |
| NCT01864642 |
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects |
https://ClinicalTrials.gov/show/NCT01864642 |
Completed |
University of Wisconsin, Madison |
2014-05-31 |
| NCT01863953 |
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01863953 |
Completed |
Allergan |
2013-12-31 |
| NCT01833741 |
A Study of LUMIGAN® RC in the Clinical Setting |
https://ClinicalTrials.gov/show/NCT01833741 |
Completed |
Allergan |
2011-03-31 |
| NCT01830140 |
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01830140 |
Completed |
Allergan |
2014-05-31 |
| NCT01789736 |
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days |
https://ClinicalTrials.gov/show/NCT01789736 |
Completed |
Aerie Pharmaceuticals |
2013-06-30 |
| NCT01749930 |
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01749930 |
Completed |
Bausch & Lomb Incorporated |
2015-05-31 |
| NCT01749904 |
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01749904 |
Completed |
Bausch & Lomb Incorporated |
2015-06-02 |
| NCT01739244 |
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01739244 |
Completed |
Sylentis, S.A. |
2013-05-31 |
| NCT01731002 |
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT01731002 |
Completed |
Aerie Pharmaceuticals |
2013-05-31 |
| NCT01722604 |
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt |
https://ClinicalTrials.gov/show/NCT01722604 |
Completed |
Bausch Health Americas, Inc. |
2012-09-30 |
| NCT01707381 |
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01707381 |
Completed |
Bausch & Lomb Incorporated |
2013-12-31 |
| NCT01699464 |
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months |
https://ClinicalTrials.gov/show/NCT01699464 |
Completed |
Aerie Pharmaceuticals |
2013-04-30 |
| NCT01693315 |
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01693315 |
Completed |
Amakem, NV |
2013-07-31 |
| NCT01687426 |
Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01687426 |
Completed |
Eye Therapies, LLC |
2012-12-31 |
| NCT01670266 |
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01670266 |
Completed |
Ono Pharmaceutical Co. Ltd |
2013-05-31 |
| NCT01668524 |
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects |
https://ClinicalTrials.gov/show/NCT01668524 |
Completed |
Altheos, Inc. |
2012-08-31 |
| NCT01664039 |
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® |
https://ClinicalTrials.gov/show/NCT01664039 |
Completed |
Alcon Research |
2014-06-30 |
| NCT01658839 |
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients |
https://ClinicalTrials.gov/show/NCT01658839 |
Completed |
Alcon Research |
2013-07-31 |
| NCT01655758 |
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01655758 |
Completed |
University of Parma |
2003-12-31 |
| NCT01654484 |
A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT |
https://ClinicalTrials.gov/show/NCT01654484 |
Completed |
Santen Inc. |
2012-11-30 |
| NCT01652664 |
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients |
https://ClinicalTrials.gov/show/NCT01652664 |
Completed |
Alcon Research |
2014-03-31 |
| NCT01594970 |
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) |
https://ClinicalTrials.gov/show/NCT01594970 |
Completed |
Allergan |
2013-01-31 |
| NCT01547598 |
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction |
https://ClinicalTrials.gov/show/NCT01547598 |
Completed |
Allergan |
2013-07-31 |
| NCT01528787 |
Study of AR-13324 in Patients With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT01528787 |
Completed |
Aerie Pharmaceuticals |
2012-07-31 |
| NCT01528111 |
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01528111 |
Completed |
Lexicon Pharmaceuticals |
2012-06-30 |
| NCT01525173 |
A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01525173 |
Completed |
Allergan |
2012-10-31 |
| NCT01510145 |
Efficacy of Changing to TRAVATAN® From Prior Therapy |
https://ClinicalTrials.gov/show/NCT01510145 |
Completed |
Alcon Research |
2013-05-31 |
| NCT01493427 |
Efficacy of Changing to TRAVATAN® From Prior Therapy |
https://ClinicalTrials.gov/show/NCT01493427 |
Completed |
Alcon Research |
2013-02-28 |
| NCT01493271 |
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01493271 |
Completed |
Hoffmann-La Roche |
2012-11-30 |
| NCT01491867 |
Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect |
https://ClinicalTrials.gov/show/NCT01491867 |
Completed |
Semmelweis University |
2012-10-31 |
| NCT01481077 |
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01481077 |
Completed |
Mati Therapeutics Inc. |
2012-09-30 |
| NCT01481051 |
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01481051 |
Completed |
Mati Therapeutics Inc. |
2012-09-30 |
| NCT01474135 |
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT01474135 |
Completed |
Aerie Pharmaceuticals |
2012-04-30 |
| NCT01471158 |
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma |
https://ClinicalTrials.gov/show/NCT01471158 |
Completed |
Alcon Research |
2011-05-31 |
| NCT01464424 |
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) |
https://ClinicalTrials.gov/show/NCT01464424 |
Completed |
Alcon Research |
2012-06-30 |
| NCT01453855 |
Travoprost 3-Month Safety and Efficacy Study |
https://ClinicalTrials.gov/show/NCT01453855 |
Completed |
Alcon Research |
2012-08-31 |
| NCT01443988 |
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost |
https://ClinicalTrials.gov/show/NCT01443988 |
Completed |
Glaukos Corporation |
2017-01-31 |
| NCT01426867 |
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% |
https://ClinicalTrials.gov/show/NCT01426867 |
Completed |
Alcon Research |
2011-11-30 |
| NCT01415401 |
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada |
https://ClinicalTrials.gov/show/NCT01415401 |
Completed |
Alcon Research |
2013-06-30 |
| NCT01410188 |
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01410188 |
Completed |
Kubota Vision Inc. |
2012-10-31 |
| NCT01379144 |
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01379144 |
Completed |
Pfizer |
2003-03-31 |
| NCT01369771 |
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma |
https://ClinicalTrials.gov/show/NCT01369771 |
Completed |
FinnMedi Oy |
2012-06-30 |
| NCT01357616 |
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01357616 |
Completed |
Alcon Research |
2013-01-31 |
| NCT01343082 |
DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01343082 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2013-03-31 |
| NCT01342094 |
DE-111 Against Timolol Ophthalmic Solution 0.5% |
https://ClinicalTrials.gov/show/NCT01342094 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2012-09-30 |
| NCT01342081 |
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% |
https://ClinicalTrials.gov/show/NCT01342081 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2012-09-30 |
| NCT01340014 |
Patient Preference Comparison of AZARGA Versus COSOPT |
https://ClinicalTrials.gov/show/NCT01340014 |
Completed |
Alcon Research |
2012-10-31 |
| NCT01336569 |
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol |
https://ClinicalTrials.gov/show/NCT01336569 |
Completed |
Alcon Research |
2012-03-31 |
| NCT01330979 |
24-hour Efficacy of AR-12286 |
https://ClinicalTrials.gov/show/NCT01330979 |
Completed |
Aerie Pharmaceuticals |
2012-08-31 |
| NCT01327599 |
Efficacy of Changing to DUOTRAV® From Prior Therapy |
https://ClinicalTrials.gov/show/NCT01327599 |
Completed |
Alcon Research |
2012-11-30 |
| NCT04285580 |
A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT04285580 |
Recruiting |
Allergan |
2021-03-12 |
| NCT04448223 |
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 |
https://ClinicalTrials.gov/show/NCT04448223 |
Recruiting |
Chong Kun Dang Pharmaceutical |
2022-12-05 |
| NCT04445519 |
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT04445519 |
Recruiting |
Nicox Ophthalmics, Inc. |
2021-12-31 |
| NCT04433702 |
Effect of Negative Pressure on Pattern Electroretinography Readings |
https://ClinicalTrials.gov/show/NCT04433702 |
Recruiting |
Vance Thompson Vision |
2020-12-31 |
| NCT04405245 |
Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypotension or Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT04405245 |
Recruiting |
Aerpio Therapeutics |
2020-12-31 |
| NCT04335825 |
Surgical and Refractive Outcomes of Combined Glaucoma Surgery |
https://ClinicalTrials.gov/show/NCT04335825 |
Completed |
Medical University of Bialystok |
2019-01-01 |
| NCT04284514 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT04284514 |
Completed |
Aerpio Therapeutics |
2019-12-15 |
| NCT04202562 |
Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade |
https://ClinicalTrials.gov/show/NCT04202562 |
Completed |
Hospital San Carlos, Madrid |
2017-11-29 |
| NCT04149899 |
Safety and IOP-Lowering Effects of WB007 |
https://ClinicalTrials.gov/show/NCT04149899 |
Recruiting |
Whitecap Biosciences, LLC |
2020-06-30 |
| NCT04133311 |
A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT04133311 |
Recruiting |
Santen SAS |
2020-12-31 |
| NCT04061044 |
A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert |
https://ClinicalTrials.gov/show/NCT04061044 |
Active, not recruiting |
Ocular Therapeutix, Inc. |
2020-02-29 |
| NCT04035239 |
Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma |
https://ClinicalTrials.gov/show/NCT04035239 |
Recruiting |
Stanford University |
2020-02-28 |
| NCT04024072 |
To Compare the Safety and Efficacy of Perrigo’s Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes |
https://ClinicalTrials.gov/show/NCT04024072 |
Active, not recruiting |
Perrigo Company |
2020-02-26 |
| NCT04005079 |
Pilocarpine After Combined Cataract/Trabectome Surgery |
https://ClinicalTrials.gov/show/NCT04005079 |
Recruiting |
Montefiore Medical Center |
2022-07-31 |
| NCT03978546 |
Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study) |
https://ClinicalTrials.gov/show/NCT03978546 |
Recruiting |
Manchester University NHS Foundation Trust |
2020-05-31 |
| NCT03931317 |
Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity |
https://ClinicalTrials.gov/show/NCT03931317 |
Recruiting |
University of California, San Diego |
2020-12-31 |
| NCT03926975 |
The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width |
https://ClinicalTrials.gov/show/NCT03926975 |
Completed |
University of Houston |
2019-06-15 |
| NCT03901781 |
Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects |
https://ClinicalTrials.gov/show/NCT03901781 |
Recruiting |
Noveome Biotherapeutics, formerly Stemnion |
2020-12-01 |
| NCT03896633 |
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt |
https://ClinicalTrials.gov/show/NCT03896633 |
Completed |
Bausch Health Americas, Inc. |
2018-11-17 |
| NCT03891446 |
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR |
https://ClinicalTrials.gov/show/NCT03891446 |
Recruiting |
Allergan |
2024-01-21 |
| NCT03868124 |
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant |
https://ClinicalTrials.gov/show/NCT03868124 |
Recruiting |
Glaukos Corporation |
2021-06-30 |
| NCT03858894 |
Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 |
https://ClinicalTrials.gov/show/NCT03858894 |
Completed |
Santen Inc. |
2019-06-20 |
| NCT03850782 |
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT03850782 |
Recruiting |
Allergan |
2023-07-17 |
| NCT03844945 |
Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan |
https://ClinicalTrials.gov/show/NCT03844945 |
Completed |
Aerie Pharmaceuticals |
2019-09-19 |
| NCT03808688 |
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting |
https://ClinicalTrials.gov/show/NCT03808688 |
Completed |
Aerie Pharmaceuticals |
2019-07-26 |
| NCT03798223 |
Optimal Treatment Protocol for Selective Laser Trabeculoplasty |
https://ClinicalTrials.gov/show/NCT03798223 |
Enrolling by invitation |
Vastra Gotaland Region |
2024-01-31 |
| NCT03697811 |
DE-117 Spectrum 5 Study |
https://ClinicalTrials.gov/show/NCT03697811 |
Recruiting |
Santen Inc. |
2020-12-31 |
| NCT03691662 |
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study |
https://ClinicalTrials.gov/show/NCT03691662 |
Active, not recruiting |
Santen Inc. |
2019-12-31 |
| NCT03691649 |
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study |
https://ClinicalTrials.gov/show/NCT03691649 |
Active, not recruiting |
Santen Inc. |
2019-12-31 |
| NCT03534882 |
Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT03534882 |
Completed |
Western University, Canada |
2017-06-22 |
| NCT03529591 |
Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT? |
https://ClinicalTrials.gov/show/NCT03529591 |
Recruiting |
Western University, Canada |
2020-07-30 |
| NCT03519386 |
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% |
https://ClinicalTrials.gov/show/NCT03519386 |
Recruiting |
Glaukos Corporation |
2021-06-30 |
| NCT03450629 |
Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT03450629 |
Recruiting |
Sun Pharma Advanced Research Company Limited |
2020-12-29 |
| NCT03419975 |
A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT03419975 |
Completed |
Taejoon Pharmaceutical Co., Ltd. |
2017-12-28 |
| NCT01263444 |
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy |
https://ClinicalTrials.gov/show/NCT01263444 |
Completed |
Alcon Research |
2013-04-30 |
| NCT01254604 |
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) |
https://ClinicalTrials.gov/show/NCT01254604 |
Completed |
Merck Sharp & Dohme Corp. |
2013-05-09 |
| NCT01254370 |
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease |
https://ClinicalTrials.gov/show/NCT01254370 |
Completed |
Santen SAS |
2011-06-30 |
| NCT01253902 |
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01253902 |
Completed |
Allergan |
2011-10-31 |
| NCT01241240 |
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01241240 |
Completed |
Allergan |
2013-09-30 |
| NCT01241175 |
The Effect of Intravenous Magnesium Sulfate on Intraocular Pressure Following Tracheal Intubation |
https://ClinicalTrials.gov/show/NCT01241175 |
Completed |
Shiraz University of Medical Sciences |
NA |
| NCT01229982 |
A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01229982 |
Completed |
Mati Therapeutics Inc. |
2011-08-31 |
| NCT01229462 |
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01229462 |
Completed |
Allergan |
2011-09-30 |
| NCT01227291 |
SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg |
https://ClinicalTrials.gov/show/NCT01227291 |
Completed |
Sylentis, S.A. |
2012-03-31 |
| NCT01223378 |
Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01223378 |
Completed |
Bausch & Lomb Incorporated |
2011-12-20 |
| NCT01217606 |
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01217606 |
Completed |
Allergan |
2014-09-30 |
| NCT01216943 |
Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01216943 |
Completed |
Allergan |
2012-08-31 |
| NCT01215786 |
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01215786 |
Completed |
Allergan |
2010-12-31 |
| NCT01177098 |
Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01177098 |
Completed |
Allergan |
2012-02-29 |
| NCT01173471 |
A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure |
https://ClinicalTrials.gov/show/NCT01173471 |
Completed |
AstraZeneca |
2012-11-30 |
| NCT01170884 |
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® |
https://ClinicalTrials.gov/show/NCT01170884 |
Completed |
Allergan |
2010-09-30 |
| NCT01168414 |
A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01168414 |
Completed |
Ministry of Health, Malaysia |
2011-01-31 |
| NCT01162603 |
Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) |
https://ClinicalTrials.gov/show/NCT01162603 |
Completed |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2012-04-30 |
| NCT01157364 |
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01157364 |
Completed |
Allergan |
2016-07-27 |
| NCT01126203 |
Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01126203 |
Completed |
University of Calgary |
2009-09-30 |
| NCT01123785 |
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT01123785 |
Completed |
Inotek Pharmaceuticals Corporation |
2011-12-31 |
| NCT01114893 |
Travoprost Five Day Posology Study |
https://ClinicalTrials.gov/show/NCT01114893 |
Completed |
Alcon Research |
2010-05-31 |
| NCT01111890 |
Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01111890 |
Completed |
Alcon Research |
2011-07-31 |
| NCT01110499 |
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01110499 |
Completed |
Allergan |
2011-05-31 |
| NCT01099774 |
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01099774 |
Completed |
Allergan |
2011-04-29 |
| NCT01068964 |
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01068964 |
Completed |
Allergan |
2010-09-01 |
| NCT01062971 |
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide |
https://ClinicalTrials.gov/show/NCT01062971 |
Completed |
Laboratorios Sophia S.A de C.V. |
2007-08-31 |
| NCT01060579 |
Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT01060579 |
Completed |
Aerie Pharmaceuticals |
2010-08-31 |
| NCT01037036 |
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG |
https://ClinicalTrials.gov/show/NCT01037036 |
Completed |
Mati Therapeutics Inc. |
2010-04-30 |
| NCT01033422 |
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT01033422 |
Completed |
Can-Fite BioPharma |
2016-12-31 |
| NCT01028664 |
Use of an Ocular Telemetry Sensor in Diamox Treated Patients |
https://ClinicalTrials.gov/show/NCT01028664 |
Completed |
Sensimed AG |
2010-10-31 |
| NCT01026831 |
Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT01026831 |
Completed |
Merck Sharp & Dohme Corp. |
2010-09-17 |
| NCT01001195 |
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT01001195 |
Completed |
Allergan |
2010-04-30 |
| NCT00990743 |
Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 |
https://ClinicalTrials.gov/show/NCT00990743 |
Completed |
Sylentis, S.A. |
2010-06-30 |
| NCT00972426 |
A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00972426 |
Completed |
Taiwan Otsuka Pharm. Co., Ltd |
2010-08-31 |
| NCT00967811 |
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG |
https://ClinicalTrials.gov/show/NCT00967811 |
Completed |
Mati Therapeutics Inc. |
2010-05-31 |
| NCT00947661 |
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00947661 |
Completed |
Sun Pharma Advanced Research Company Limited |
2012-05-31 |
| NCT00945958 |
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00945958 |
Completed |
Sun Pharma Advanced Research Company Limited |
2012-06-30 |
| NCT00941525 |
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT00941525 |
Completed |
Aristotle University Of Thessaloniki |
2014-07-31 |
| NCT00941096 |
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination |
https://ClinicalTrials.gov/show/NCT00941096 |
Completed |
Larissa University Hospital |
2010-11-30 |
| NCT00934089 |
A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 |
https://ClinicalTrials.gov/show/NCT00934089 |
Completed |
Pfizer |
2010-06-30 |
| NCT00928590 |
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00928590 |
Completed |
Alcon Research |
2010-11-30 |
| NCT00918346 |
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation |
https://ClinicalTrials.gov/show/NCT00918346 |
Completed |
Santen Oy |
2006-03-31 |
| NCT00906594 |
Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure |
https://ClinicalTrials.gov/show/NCT00906594 |
Completed |
University of Sao Paulo |
2008-01-31 |
| NCT03870230 |
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03870230 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT00902200 |
A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) |
https://ClinicalTrials.gov/show/NCT00902200 |
Completed |
Aerie Pharmaceuticals |
2009-09-30 |
| NCT00892762 |
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health |
https://ClinicalTrials.gov/show/NCT00892762 |
Completed |
Alcon Research |
2011-05-31 |
| NCT00887029 |
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00887029 |
Completed |
Ophthalmic Consultants Centres, Canada |
2009-11-30 |
| NCT00878917 |
Equivalence Study of Dorzolamide 2% Eye Drops Solution |
https://ClinicalTrials.gov/show/NCT00878917 |
Completed |
Alfred E. Tiefenbacher (GmbH & Co. KG) |
2010-02-28 |
| NCT00872651 |
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00872651 |
Completed |
Alcon Research |
2011-11-30 |
| NCT00868894 |
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00868894 |
Completed |
Santen Inc. |
2010-05-31 |
| NCT00864838 |
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab |
https://ClinicalTrials.gov/show/NCT00864838 |
Completed |
University of Sao Paulo |
2009-02-28 |
| NCT00856622 |
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients |
https://ClinicalTrials.gov/show/NCT00856622 |
Completed |
Pfizer |
1999-06-30 |
| NCT00848536 |
Efficacy Study of Travoprost APS Versus TRAVATAN |
https://ClinicalTrials.gov/show/NCT00848536 |
Completed |
Alcon Research |
2010-01-31 |
| NCT00847483 |
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US |
https://ClinicalTrials.gov/show/NCT00847483 |
Completed |
Pfizer |
2002-08-31 |
| NCT00846989 |
Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00846989 |
Completed |
Novartis |
2009-04-30 |
| NCT00845299 |
Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00845299 |
Completed |
Mati Therapeutics Inc. |
2009-12-31 |
| NCT00838721 |
Evaluation of Pascal Laser Trabeculoplaty |
https://ClinicalTrials.gov/show/NCT00838721 |
Completed |
Santa Clara Valley Health & Hospital System |
2010-03-31 |
| NCT04360174 |
CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT04360174 |
Recruiting |
Ocular Therapeutix, Inc. |
2020-10-31 |
| NCT02136940 |
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02136940 |
Completed |
Amakem, NV |
2014-11-30 |
| NCT01087671 |
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops |
https://ClinicalTrials.gov/show/NCT01087671 |
Completed |
Santen Oy |
2010-10-31 |
| NCT01016691 |
Safety and Efficacy of a Drug Delivery System in Glaucoma |
https://ClinicalTrials.gov/show/NCT01016691 |
Completed |
Vistakon Pharmaceuticals |
2010-02-28 |
| NCT00828906 |
DuoTrav® Eye Drops As Replacement Therapy Program |
https://ClinicalTrials.gov/show/NCT00828906 |
Completed |
Alcon Research |
2009-11-30 |
| NCT00825396 |
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00825396 |
Completed |
Chakshu Research, Inc. |
2009-04-30 |
| NCT00824720 |
Safety and Efficacy of a Glaucoma Drug Delivery System |
https://ClinicalTrials.gov/show/NCT00824720 |
Completed |
Vistakon Pharmaceuticals |
2009-04-30 |
| NCT00822081 |
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00822081 |
Completed |
Bp Consulting, Inc |
2006-04-30 |
| NCT00822055 |
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00822055 |
Completed |
Allergan |
2006-11-30 |
| NCT03960866 |
Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma |
https://ClinicalTrials.gov/show/NCT03960866 |
Completed |
Ocuphire Pharma, Inc. |
2019-09-11 |
| NCT02003534 |
A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02003534 |
Completed |
Allergan |
2013-02-28 |
| NCT00811564 |
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects |
https://ClinicalTrials.gov/show/NCT00811564 |
Completed |
Allergan |
2010-01-31 |
| NCT00809848 |
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00809848 |
Completed |
Allergan |
2009-05-31 |
| NCT02003547 |
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02003547 |
Completed |
Amakem, NV |
2013-12-31 |
| NCT01943721 |
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT01943721 |
Completed |
ForSight Vision5, Inc. |
2014-06-30 |
| NCT01896180 |
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost |
https://ClinicalTrials.gov/show/NCT01896180 |
Completed |
Alleanza Pharmaceuticals, Inc. |
2014-01-31 |
| NCT00804648 |
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00804648 |
Completed |
Vistakon Pharmaceuticals |
2008-12-31 |
| NCT02914509 |
OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT02914509 |
Completed |
Ocular Therapeutix, Inc. |
2019-03-30 |
| NCT02371746 |
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT02371746 |
Completed |
Envisia Therapeutics |
2019-02-13 |
| NCT02325518 |
Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT02325518 |
Completed |
Alcon Research |
2015-12-31 |
| NCT00781300 |
Intraocular Pressure With Loteprednol and Dexamethasone |
https://ClinicalTrials.gov/show/NCT00781300 |
Completed |
Federal University of São Paulo |
2006-11-30 |
| NCT00763061 |
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00763061 |
Completed |
Alcon Research |
2008-04-30 |
| NCT00761995 |
Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00761995 |
Completed |
Alcon Research |
2010-07-31 |
| NCT00761709 |
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00761709 |
Completed |
Alcon Research |
2009-10-31 |
| NCT00761319 |
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health |
https://ClinicalTrials.gov/show/NCT00761319 |
Completed |
Alcon Research |
2009-09-30 |
| NCT00760539 |
Safety and Efficacy of Travoprost/Timolol BAC-free |
https://ClinicalTrials.gov/show/NCT00760539 |
Completed |
Alcon Research |
2008-12-31 |
| NCT00759239 |
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00759239 |
Completed |
Alcon Research |
2011-01-31 |
| NCT00753168 |
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00753168 |
Completed |
Othera Pharmaceuticals |
2008-12-31 |
| NCT00751127 |
A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00751127 |
Completed |
Pfizer |
1994-02-28 |
| NCT00751062 |
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia |
https://ClinicalTrials.gov/show/NCT00751062 |
Completed |
Pfizer |
1993-12-31 |
| NCT00751049 |
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom |
https://ClinicalTrials.gov/show/NCT00751049 |
Completed |
Pfizer |
1993-12-31 |
| NCT00708422 |
Effects of Travatan Z and Xalatan on Ocular Surface Health |
https://ClinicalTrials.gov/show/NCT00708422 |
Completed |
Alcon Research |
2009-08-31 |
| NCT00706927 |
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00706927 |
Completed |
Medical University of Vienna |
2010-08-31 |
| NCT00698945 |
Comparison of Istalolâ„¢ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) |
https://ClinicalTrials.gov/show/NCT00698945 |
Completed |
Bp Consulting, Inc |
2008-11-30 |
| NCT00691717 |
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00691717 |
Completed |
Alcon Research |
2009-09-30 |
| NCT00690794 |
Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00690794 |
Completed |
Alcon Research |
2009-05-31 |
| NCT00683501 |
Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure |
https://ClinicalTrials.gov/show/NCT00683501 |
Completed |
Danube Pharmaceuticals, Inc. |
2008-08-31 |
| NCT00675207 |
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs |
https://ClinicalTrials.gov/show/NCT00675207 |
Completed |
Northwestern Ophthalmic Institute S.C. |
2007-07-31 |
| NCT00672997 |
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00672997 |
Completed |
Alcon Research |
2008-12-31 |
| NCT00670033 |
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00670033 |
Completed |
Alcon Research |
2008-09-30 |
| NCT00657579 |
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00657579 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT00656240 |
To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00656240 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT00652496 |
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00652496 |
Completed |
Allergan |
2005-05-31 |
| NCT00652483 |
Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00652483 |
Completed |
Allergan |
2003-12-31 |
| NCT00652106 |
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00652106 |
Completed |
Allergan |
2004-03-31 |
| NCT00651859 |
Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00651859 |
Completed |
Allergan |
2004-01-31 |
| NCT00651612 |
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00651612 |
Completed |
Allergan |
2007-01-31 |
| NCT00650702 |
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00650702 |
Completed |
Mati Therapeutics Inc. |
2009-02-28 |
| NCT00650338 |
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00650338 |
Completed |
Santen Inc. |
2008-09-30 |
| NCT00821002 |
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) |
https://ClinicalTrials.gov/show/NCT00821002 |
Completed |
Mati Therapeutics Inc. |
2009-11-30 |
| NCT00647101 |
A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00647101 |
Completed |
Pfizer |
NA |
| NCT00638742 |
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. |
https://ClinicalTrials.gov/show/NCT00638742 |
Completed |
Pfizer |
2009-03-31 |
| NCT00637130 |
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost |
https://ClinicalTrials.gov/show/NCT00637130 |
Completed |
Alcon Research |
2008-01-31 |
| NCT00620256 |
Adjunctive Study of AL-37807 Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT00620256 |
Completed |
Alcon Research |
2008-07-31 |
| NCT00596791 |
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops |
https://ClinicalTrials.gov/show/NCT00596791 |
Completed |
Santen Oy |
2008-07-31 |
| NCT00800267 |
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States |
https://ClinicalTrials.gov/show/NCT00800267 |
Completed |
Pfizer |
1999-06-30 |
| NCT00595101 |
A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. |
https://ClinicalTrials.gov/show/NCT00595101 |
Completed |
Bausch & Lomb Incorporated |
2008-06-30 |
| NCT00576342 |
Patient Preference Study |
https://ClinicalTrials.gov/show/NCT00576342 |
Completed |
Alcon Research |
2008-01-31 |
| NCT00572455 |
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. |
https://ClinicalTrials.gov/show/NCT00572455 |
Completed |
Pfizer |
2009-06-30 |
| NCT00546286 |
A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) |
https://ClinicalTrials.gov/show/NCT00546286 |
Completed |
Merck Sharp & Dohme Corp. |
2007-08-23 |
| NCT00545064 |
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00545064 |
Completed |
Merck Sharp & Dohme Corp. |
2008-09-15 |
| NCT00541242 |
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00541242 |
Completed |
Allergan |
2008-08-31 |
| NCT00539526 |
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues |
https://ClinicalTrials.gov/show/NCT00539526 |
Completed |
Allergan |
2008-07-31 |
| NCT00538304 |
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00538304 |
Completed |
Allergan |
2008-05-31 |
| NCT00527592 |
A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00527592 |
Completed |
Alcon Research |
2008-08-31 |
| NCT00527501 |
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00527501 |
Completed |
Alcon Research |
2007-12-31 |
| NCT00515424 |
Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00515424 |
Completed |
Novartis |
NA |
| NCT00508469 |
Adherence Assessment With Travalert Dosing Aid |
https://ClinicalTrials.gov/show/NCT00508469 |
Completed |
Alcon Research |
2010-01-31 |
| NCT00503360 |
Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00503360 |
Completed |
Novartis |
NA |
| NCT00471380 |
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00471380 |
Completed |
Alcon Research |
2008-10-31 |
| NCT00465803 |
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00465803 |
Completed |
Alcon Research |
2009-01-31 |
| NCT00465621 |
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00465621 |
Completed |
Alcon Research |
2007-07-31 |
| NCT00457795 |
24-hour IOP-lowering Effect of Brimonidine 0.1% |
https://ClinicalTrials.gov/show/NCT00457795 |
Completed |
Allergan |
2009-02-28 |
| NCT00449956 |
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00449956 |
Completed |
Merck Sharp & Dohme Corp. |
2008-02-16 |
| NCT00443924 |
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma |
https://ClinicalTrials.gov/show/NCT00443924 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-30 |
| NCT00441883 |
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma |
https://ClinicalTrials.gov/show/NCT00441883 |
Completed |
Bausch & Lomb Incorporated |
2008-02-29 |
| NCT00440141 |
Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% |
https://ClinicalTrials.gov/show/NCT00440141 |
Completed |
Allergan |
2007-03-31 |
| NCT00440011 |
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% |
https://ClinicalTrials.gov/show/NCT00440011 |
Completed |
Allergan |
2007-10-31 |
| NCT00402493 |
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops |
https://ClinicalTrials.gov/show/NCT00402493 |
Completed |
Philadelphia Eye Associates |
2008-03-31 |
| NCT00820300 |
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma |
https://ClinicalTrials.gov/show/NCT00820300 |
Completed |
Mati Therapeutics Inc. |
2009-12-31 |
| NCT00383019 |
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). |
https://ClinicalTrials.gov/show/NCT00383019 |
Completed |
Pfizer |
2007-10-31 |
| NCT00372931 |
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00372931 |
Completed |
Alcon Research |
2007-08-31 |
| NCT00372827 |
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00372827 |
Completed |
Alcon Research |
2006-01-31 |
| NCT00314171 |
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00314171 |
Completed |
Alcon Research |
2007-08-31 |
| NCT00348062 |
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00348062 |
Completed |
Innovative Medical |
NA |
| NCT00348023 |
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00348023 |
Completed |
Innovative Medical |
NA |
| NCT00333125 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00333125 |
Completed |
Alcon Research |
2007-02-28 |
| NCT00332540 |
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332540 |
Completed |
Allergan |
2003-08-31 |
| NCT00332436 |
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332436 |
Completed |
Allergan |
2001-11-30 |
| NCT00332384 |
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332384 |
Completed |
Allergan |
2001-11-30 |
| NCT00332345 |
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332345 |
Completed |
Allergan |
1999-08-31 |
| NCT00332072 |
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332072 |
Completed |
Allergan |
2003-08-31 |
| NCT00332059 |
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00332059 |
Completed |
Allergan |
2004-09-30 |
| NCT00330577 |
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00330577 |
Completed |
Aristotle University Of Thessaloniki |
2007-04-30 |
| NCT00329095 |
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance |
https://ClinicalTrials.gov/show/NCT00329095 |
Completed |
Robin, Alan L., M.D. |
NA |
| NCT00326092 |
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00326092 |
Completed |
Alcon Research |
2006-08-31 |
| NCT00314158 |
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00314158 |
Completed |
Alcon Research |
2007-01-31 |
| NCT00311389 |
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00311389 |
Completed |
Alcon Research |
2004-09-30 |
| NCT00304785 |
Latanoprost Versus Fotil |
https://ClinicalTrials.gov/show/NCT00304785 |
Completed |
Pharmaceutical Research Network |
NA |
| NCT00300443 |
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00300443 |
Completed |
Allergan |
2007-06-30 |
| NCT00300079 |
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00300079 |
Completed |
Alcon Research |
2007-09-30 |
| NCT00293800 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00293800 |
Completed |
Alcon Research |
2005-12-31 |
| NCT00293787 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00293787 |
Completed |
Alcon Research |
2005-08-31 |
| NCT00293761 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00293761 |
Completed |
Alcon Research |
2006-05-31 |
| NCT00288951 |
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00288951 |
Completed |
Alcon Research |
2005-06-30 |
| NCT00287521 |
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00287521 |
Completed |
Alcon Research |
2006-02-28 |
| NCT00277498 |
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma |
https://ClinicalTrials.gov/show/NCT00277498 |
Completed |
Pfizer |
NA |
| NCT00273481 |
Cosopt Versus Xalacom |
https://ClinicalTrials.gov/show/NCT00273481 |
Completed |
Pharmaceutical Research Network |
NA |
| NCT00273442 |
Assessing Cosopt Switch Patients |
https://ClinicalTrials.gov/show/NCT00273442 |
Completed |
Pharmaceutical Research Network |
NA |
| NCT00273429 |
Cosopt Versus Xalatan |
https://ClinicalTrials.gov/show/NCT00273429 |
Completed |
Pharmaceutical Research Network |
NA |
| NCT00230763 |
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure |
https://ClinicalTrials.gov/show/NCT00230763 |
Completed |
Pfizer |
2007-10-31 |
| NCT00798759 |
Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN |
https://ClinicalTrials.gov/show/NCT00798759 |
Completed |
Alcon Research |
2009-05-31 |
| NCT00168363 |
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00168363 |
Completed |
Allergan |
2006-08-31 |
| NCT00159653 |
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma |
https://ClinicalTrials.gov/show/NCT00159653 |
Completed |
Pfizer |
2007-06-30 |
| NCT00143208 |
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. |
https://ClinicalTrials.gov/show/NCT00143208 |
Completed |
Pfizer |
NA |
| NCT00140062 |
Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. |
https://ClinicalTrials.gov/show/NCT00140062 |
Completed |
Pfizer |
NA |
| NCT00140049 |
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma |
https://ClinicalTrials.gov/show/NCT00140049 |
Completed |
Pfizer |
NA |
| NCT00121147 |
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan |
https://ClinicalTrials.gov/show/NCT00121147 |
Completed |
Hermann Eye Center |
NA |
| NCT00108017 |
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00108017 |
Completed |
Merck Sharp & Dohme Corp. |
2006-07-31 |
| NCT00069719 |
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00069719 |
Completed |
Alcon Research |
2003-08-31 |
| NCT00069706 |
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients |
https://ClinicalTrials.gov/show/NCT00069706 |
Completed |
Alcon Research |
2003-10-31 |
| NCT00061542 |
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00061542 |
Completed |
Alcon Research |
2006-11-30 |
| NCT00061529 |
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00061529 |
Completed |
Alcon Research |
2004-07-31 |
| NCT00061516 |
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00061516 |
Completed |
Alcon Research |
2006-02-28 |
| NCT00061503 |
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00061503 |
Completed |
Alcon Research |
2004-03-31 |
| NCT00051168 |
A Long-term Safety Study of Once-daily Travatan |
https://ClinicalTrials.gov/show/NCT00051168 |
Completed |
Alcon Research |
2009-03-31 |
| NCT00051155 |
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) |
https://ClinicalTrials.gov/show/NCT00051155 |
Completed |
Alcon Research |
2004-07-31 |
| NCT00051142 |
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) |
https://ClinicalTrials.gov/show/NCT00051142 |
Completed |
Alcon Research |
2004-06-30 |
| NCT00047541 |
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 |
https://ClinicalTrials.gov/show/NCT00047541 |
Completed |
Alcon Research |
2003-11-30 |
| NCT00047528 |
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 |
https://ClinicalTrials.gov/show/NCT00047528 |
Completed |
Alcon Research |
2003-11-30 |
| NCT00047515 |
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 |
https://ClinicalTrials.gov/show/NCT00047515 |
Completed |
Alcon Research |
2003-12-31 |
| NCT00047593 |
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 |
https://ClinicalTrials.gov/show/NCT00047593 |
Completed |
Alcon Research |
2004-07-31 |
| NCT00735449 |
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects |
https://ClinicalTrials.gov/show/NCT00735449 |
Completed |
Allergan |
2009-12-31 |
| NCT00799682 |
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® |
https://ClinicalTrials.gov/show/NCT00799682 |
Completed |
Ophthalmic Consultants of Long Island |
2011-01-31 |
| NCT00051194 |
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00051194 |
Completed |
Alcon Research |
2003-07-31 |
| NCT00051181 |
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma |
https://ClinicalTrials.gov/show/NCT00051181 |
Completed |
Alcon Research |
2003-06-30 |
| NCT00150267 |
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00150267 |
Completed |
Pfizer |
NA |
| NCT00219596 |
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension |
https://ClinicalTrials.gov/show/NCT00219596 |
Completed |
Pfizer |
NA |
| NCT00000125 |
Ocular Hypertension Treatment Study (OHTS) |
https://ClinicalTrials.gov/show/NCT00000125 |
Completed |
Washington University School of Medicine |
2002-06-30 |